Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.
Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.
As part of this report's coverage, the following data is included:
The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.
As part of Kalorama Information's comprehensive coverage of Point of Care Diagnostics the following companies are discussed:
Related Reports:Progress in Blood Testing in China
May 25, 2016 - KLI15011142 - $0.00
Surgical Procedure Volumes: Global Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, France, Italy, Mexico, Australia, Canada)
May 20, 2016 - KLI15006734 - $4,200.00
White Paper: The Market Share Picture in Molecular Diagnostics
May 18, 2016 - KLI15004299 - $0.00
5 Important Trends in EHR: White Paper
May 18, 2016 - KLI15004291 - $0.00
The Global Market for Medical Devices, 7th Edition
May 13, 2016 - KLI15002686 - $1,500.00
Blood Testing Market in China (Typing, Immunoassay, NAT Testing)
Apr 20, 2016 - KLI5975604 - $2,500.00
EMR 2016: The Market for Electronic Medical Records
Apr 13, 2016 - KLI5971507 - $4,200.00
Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)
Mar 25, 2016 - KLI5948213 - $4,200.00
Mar 24, 2016 - KLI5948135 - $2,500.00
The Market and Potential for Molecular Point of Care Diagnostics
Feb 26, 2016 - KLI5916011 - $4,200.00
Questions?Contact a research specialist >
Live Chat Software
Most Popular ResearchThe Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition The 2015 IVD Market: Year in Review Top IVD Market Trends to Watch in 2016 Retail Clinics 2015: Growth of Stores, Consumer Opinion, Leading Competitors, Sales of Products to Clinics (Diagnostic Tests, Pharmaceuticals, Vaccines), Clinic Sales Forecasts and Trends The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations) IVD Procedure Volumes and Pricing Analysis